The patient has been admitted with fever for 2 months and pallorness for 2 months. Differential diagnoses include aplastic anemia, Fanconi anemia, and leukemia. Aplastic anemia is suggested by pancytopenia and bone marrow hypocellularity. It can be inherited or acquired from radiation, chemicals, drugs, or infections. Clinical features include bleeding, anemia symptoms, and risk of infection. Bone marrow biopsy will show a fatty, dilute specimen. Treatment options include growth factors, immunosuppression, stem cell transplant, or supportive care.
Interactive talk on common hematological and oncological emergencies - which if not noticed early can lead to irreversible complications and death .
Intended to be used for educational purposes for the fertile minds in medicine .
Interactive talk on common hematological and oncological emergencies - which if not noticed early can lead to irreversible complications and death .
Intended to be used for educational purposes for the fertile minds in medicine .
A case presentation and discussion of ALL presented in a Tertiary Care Hospital ER. Includes presenting complaints, work-up, diagnosis and relevant case discussion.
A case presentation and discussion of ALL presented in a Tertiary Care Hospital ER. Includes presenting complaints, work-up, diagnosis and relevant case discussion.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
4. History
• 10 yrs old Boy Adnan Ali S/O Imtiaz Ali having
weight 25 kg, resident of Saleh patt, admitted
through E.R in Paediatric ward with following
complaint:
Fever for 2 month
Pallorness for 2 month
5. HOPC
• According to statement of my patient’s mother
,he was in usual state of health 2 months back ,
then he develop fever which was low grade,
gradual in onset, continuous, short time being
relieved with anti pyretics medication, fever was
not associated with chills, rigors.
• Patient has also complaint of Pallorness, which
was progressive 1st appears at Palm and face than
gradually had been evident at all over the body
parts. It was not associated with bleeding, bone
pain or edema.
6. Cont.....
• During this period of 02 months they went to
nearby G.P couple of times ,where they were
treated with oral suspension and antipyretics,
proper investigations were not done.
7. SYSTEMIC INQUIRY
GENERAL: H/o weight loss, appetite and sleep
normal
GIT: no complain of Diarrhea , no h/o constipation
or blood in stool.
GENITOURINARY: No complain of Oligouria,
polyurea or haematuria.
CHEST: complain cough, but no history of
hemoptysis and shortness of breath.
CVS: no palpitation, chest pain or pedal edema .
LOCOMOTOR: No complain of pain, restricted
movements and tenderness of bone or joint.
CNS: No complain of fits, altered behavior,
headache, blackout, diplopia.
9. Partially vaccinated
(BCG Scar was absent)
FAMILY HISTORY:
4 siblings, all healthy and alive
Total 06 family members
he is second product of consaguineous marriage, delivered via NVD
at home
No history D.M, HTN, T.B,
No h/o IV drug abuser in family
No history of blood transfusion in family
10. Child is school going
Good performance in school
Sleep, and bowel habits are normal
Appetite is decreased
11. lives in well ventilated house with 03 rooms and 1 washroom
Father is labor by profession
Use hand-pump water
12. NEUTRITIONAL HISTORY
• Required calories at this age are 1600kcal /day
but daily intake of my patient is 1300 kcal/day
There is no history of PICA.
13. Transfusion History
History of two times transfusion with whole
blood during this illness one 02 month back,
second 01 month back advised by GP, with no
any lab documention.
14. Sick look male child,
conscious, alert,, child lying
on bed having cannula on left
hand with following vitals
HR: 98 Beat/mint
RR: 22 breath/mint
Temp: 99 F
Blood pressure: 110/70
( both sys & dia <90TH
centile)
SUBVITALS
A+, Cl-, J-, C- ,E-
Lymph nodes not palpable
BCG scar present
ANTHROPOMETRIC
MEASUREMENTS:
weight= 25 kg (5th centile)
Height=128 cm ( at 10th
Centile)
15. ABDOMEN:
INSPECTION:
distended, moving with respiration
Umbilicus centrally placed
No visible scar marks ,straie, veins or pulsations
Hernial orifices intact
PALPATION:
Soft, non-tender, no visceromegally
AUSCULTATION:
bowel sounds audible
16. SKIN EXAMINATION
• multiples rashes of purplish blue in color all
over body but more over the face and limbs of
different sizes ranges from 5mm to 1cm non
palpable non blanchable with regular margins
no oozing of blood.
• Having normal scalp hair and nails .
17.
18. ON INSPECTION:
Respiration abdomino-thoracic, chest moving equally with
respiration, no any scar mark, bulging or veins visible, r/r was
22/min…
PALPATION AND PERCUSSION:
trachea centrally placed, further not significant.
ON AUSCULTATION:
Normal vesicular breath, air entry equal on both sides….
19. Chest normal shaped, no bulging scar mark
No pulsations observed
Apex beat at 4th inter costal space medial to midclavicular line
No heave, thrill
S1+ S2 audible
No murmur
CNS EXAMINATION:
INTACT
20. • 10 years old male child Adnan Ali S/O Imtiaz Ali, admitted in
paeds ward with c/o fever, fever not a/s with rigors and chills
for one month, Pallorness for one month. Having multiple rashes
of purplish blue in color all over body but more over the face and
limbs, ranges from 5mm to 1cm non palpable, non blanchable ,with
regular margins. Pt is partially vaccinated .On examination
patient is pale looking having weight 25 kg, height 110cm,BP
110/70,temp99 f .
21.
22. BASED ON HISTORY AND EXAMINATON
THE DIFFERENTIALS ARE
• Aplastic anemia
• Fanconi anemia
• Leukemia
35. Aplastic anemia is pancytopenia with bone marrow
hypocellularity.
Male and Female are affected with equal frequency.
Age distribution is biphasic, with the major peak in the
teens and twenties and a second rise in older adults.
INTRODUCTION
38. RADIATION
Marrow aplasia can be an acute sequale to
radiation.
Nuclear accidents.
MDS and leukemia, aplastic anemia, are late
effects of radiation.
CHEMICALS
Benzene
39. DRUGS-
Agents that regularly produce marrow depression as
major toxicity in commonly employed doses or normal
exposures: Cytotoxic drugs (alkylating agents,
antimetabolites, antimitotics), some antibiotics.
Agents that frequently but not inevitably produce marrow
aplasia: Benzene
Agents associated with aplastic anemia but with a
relatively low probability: Chloramphenicol,
Anticonvulsants.
40. INFECTIONS
-
Hepatitis (non-A, non-B, non-C) is the most
common preceding infection.
Infectious mononucleosis & parvo virus B19 in
some cases
Rarely other bacterial & viral infections
41. FANCONI’s ANEMIA-
Autosomal recessive disorder
Chromosomes in Fanconi's anemia are peculiarly
susceptible to DNA cross-linking agent
The most common, type A Fanconi's anemia, is
due to a mutation in FANCA.
manifests as congenital developmental anomalies
(short stature, café au lait spots, and anomalies
involving the thumb, radius, and genitourinary
tract), progressive pancytopenia, and an increased
risk of malignancy
42. DYSKERATOSIS CONGENITA-
X- linked, in some cases autosomal dominant
mutations in genes of the telomere repair complex
Characterized by Mucous membrane leukoplasia, dystrophic
nails, reticular hyperpigmentation, and the development of
aplastic anemia in childhood.
SHWACHMAN- DIAMOND SYNDRME-
compound heterozygous mutations in SBDS
Marrow failure + Pancreatic insufficiency and malabsorption.
43. PATHOPHYSIOLOGY
Bone marrow failure results from severe damage to the
hematopoietic cell compartment.
There is replacement of the bone marrow by fat.
An intrinsic stem cell defect exists for the constitutional
aplastic anemias
Extrinsic damage to the marrow follows massive physical
or chemical insults such as high doses of radiation and
toxic chemicals
Immune mediators like Helper T cells, TNF, IFN-ϒ may be
involved in the pathogenesis.
44. CLINICAL PRESENTATION
can appear seeming abruptly or have a more insidious
onset.
Bleeding is the most common early symptom. Easy
bruising, oozing from the gums, epistaxis, heavy
menstrual flow, and sometimes petechie (massive
hemorrhage is unusual)
Symptoms of anemia are also frequent, including
lassitude, weakness & shortness of breath.
Infection (due to leukopenia) is an unusual first
symptom in aplastic anemia.
45. CLINICAL EXAMINATION
Petechiae and ecchymoses
Pallor
Retinal hemorrhage
Look for other features associated with inherited
causes
Lymphadenopathy and splenomegaly are highly
atypical of aplastic anemia.
46.
47. INVESTIGATIONS
BLOOD-
Smear shows large erythrocytes and a paucity of
platelets and granulocytes.
Reticulocytes are absent or few.
BONE MARROW-
fatty biopsy specimen may be grossly pale
Dilute smear
“Dry tap" instead suggests fibrosis or myelophthisis
48.
49. TREATMENT
Hematopoietic growth factors
Immunosuppression
Stem cell transplantation
Supplementation of blood products and supportive
care
50. Hematopoietic growth factors-
Limited usefulness
Stem cell transplantation-
This is the best therapy for the younger patient with a
fully histocompatible sibling donor.
For allogeneic transplant from fully matched siblings,
long-term survival rates for children are approximately
90%.
51. Immunosuppression-
As most of patients lack suitable donor, it is the
treatment of choice for them.
ALG + Cyclosporine+ Corticostriods => induces
hematologic recovery in ≈ 65 % of cases.
Relapse is frequent, usually after withdrawl of
cyclosporine.
52. Methyl prednisolone alone is given in single dose of 5
mg/kg/day PO or I/V for 8 days followed by single
dose of 1 mg /kg/day for 6 days taper dose in next 6
days then discontinue, steroid response alone is 25 %.
ALG is given as 40mg/kg/dose continuous I/V infusion
over 12 hours with methyl prednisolone 1mg/kg/day
I/V for 4 days .ALG alone gives about 50% response
rate.
Cyclosporin is given orally in a dose of 8 mg/kg/day for
initial 14 days then 15mg/kg/day. Continue treatment
for minimum 3 months .
53. OTHER TREATMENT MODALITIES
Intravenous immunoglobulins
Anti thymocytic globulins
Recombination human IL-3
Gene therapy